Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FNTA | P49354 | 8/20 | 0.58 |
| ▸ | FNTB | P49356 | 8/20 | 0.58 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | ATM | Q13315 | 1/20 | 0.47 |
| ▸ | SLC6A15 | Q9H2J7 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1978262 | 0.84 | FNTA (0.60) | FNTAFNTB | |
| SCHEMBL6176740 | 0.82 | FNTA (0.58) | FNTAFNTB | |
| SCHEMBL14289895 | 0.82 | FNTA (0.58) | FNTAFNTBSLC6A15 | |
| SCHEMBL13604336 | 0.82 | FNTA (0.55) | FNTAFNTBSLC6A15 | |
| SCHEMBL22193900 | 0.81 | HTR2A (0.39) | FNTAFNTB | |
| SCHEMBL8355428 | 0.81 | HTR2A (0.39) | FNTAFNTB | |
| SCHEMBL18067707 | 0.79 | HTR2C (0.56) | FNTAFNTB | |
| SCHEMBL14288461 | 0.78 | MEN1 (0.56) | FNTAFNTBMEN1KMT2AATM | |
| SCHEMBL13611672 | 0.77 | FNTA (0.50) | FNTAFNTB | |
| SCHEMBL14102189 | 0.77 | MEN1 (0.58) | FNTAFNTBMEN1KMT2AATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7635697-B2 | Farnesyl protein transferase inhibitors and methods for treating proliferative diseases | SCHERING CORPORATION (US) | 2009-12-22 | — | — | US | disclosed |
| EP-1318994-B1 | SUBSTITUTED IMIDAZOLES AS DUAL HISTAMINE H1 AND H3 AGONISTS OR ANTAGONISTS | SCHERING CORP (US) | 2008-02-27 | — | — | EP | disclosed |